Drugs / Trixiera
last change Jan 2021 re-read 3 minutes ago

Trixiera

Developed for
radiodermatitis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT02334345 Comparator Jan → Nov 2015 radiodermatitis University Hospital, Limoges Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Trixiera ClinicalTrials.gov intervention name — accepted as the source's own label NCT02334345 ↗
Route Topical “Patients are to apply Trixiera ( topical agent) in the other half of the irradiated breast 3 hours after radiothérapy and may be applied again later the same day.” NCT02334345 ↗